Biogen
Latest
FDA approves first oral postpartum depression pill
The FDA approves a new pill for postpartum depression. The drug was developed by Biogen and Sage.The approval is based on research that backs the oral drug's effectiveness.
The first drug that slows Alzheimer's has finally received FDA approval
Japanese drugmaker Eisai and US-based Biogen have received FDA approval for Leqembi, making it the first approved treatment available that can slow the progression of Alzheimer’s in patients.
Apple is reportedly working on mental health monitoring using iPhone data
Sensors and algorithms could help detect depression, anxiety and cognitive decline.
